Morgan Stanley Inaugural Private Company & Investor Day on May 5 Dr. Jonathan Kil, Co-Founder and CEO will provide an update on SPI-1005, the novel oral anti-inflammatory, the first investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results